Assyro AI

Orange Book product · Brand (NDA)

IYUZEH

LATANOPROST

Brand (NDA)NDA 216472RX THEA PHARMA

At a glance

Dec 13, 2022

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 13, 2022

    3 yr 7 mo ago

  2. Today

  3. Patent 8637054 expires

    Listed drug product patent expiration.

    Jul 08, 2031

    in 5 yr 2 mo

Pharmaceutical detail

Active ingredient

LATANOPROST

Strength

0.005%

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

NDA 216472

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8637054Jul 08, 2031in 5 yr 2 mo
ProductU-446
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.